Kyle Dempsey

Dr. Kyle Dempsey, MD, MBA, specializes in investing in commercial-stage healthcare and life science companies, focusing on subsectors such as medical technology/devices, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and research tools.

He seeks target investment opportunities that address significant unmet needs in large addressable markets, particularly in medical conditions with inadequate treatments, expensive therapies, and diseases lacking accurate diagnostic capabilities, along with supporting businesses and products.

Dr. Dempsey holds impressive educational credentials, including an M.D. with Magna cum Laude honors from Harvard Medical School, an MBA from Harvard Business School, and a Bachelor of Arts with Honors in Biochemistry and a Minor in Economics, also with Magna cum Laude honors, from Bowdoin College.

Currently, Dr. Dempsey serves as a Partner at MVM Partners LLP. He has held various key roles in notable organizations, including being a former Board Member at GT Medical Technologies, Inc., former Board Observer at MDxHealth and Biotheranostics, Inc., former Investment Principal at MVM Partners LLP, and former Consultant at Bain & Company.

His professional background also includes roles in research and healthcare leadership capacities, such as Surgery Outcomes Research at Brigham and Women's Hospital, Co-Chair at the American Medical Association, Clinic Director at Massachusetts General Hospital, serving on research teams, and as a Board Member.